Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S146000, C548S200000
Reexamination Certificate
active
07863304
ABSTRACT:
Embodiments of this invention include novel analogs of Glycyl-Prolyl-Glutamate (GPE) and compositions containing such analogs of GPE. Of these, certain analogs have modified proline residues. Other embodiments of this invention include uses of analogs of GPE to protect neural cells from degeneration and/or death in response to injury or disease. Disorders treatable with compounds and compositions of this invention include hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease.
REFERENCES:
patent: 6682753 (2004-01-01), Alexi
patent: 7041314 (2006-05-01), Abood et al.
patent: 7605177 (2009-10-01), Gluckman et al.
Gluckman et al (2002): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 2002:157813.
Zaczek et al (1993): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 1993:617294.
Brimble Margaret Anne
Harris Paul William Richard
Sieg Frank
Borson D. Benjamin
Neuren Pharmaceuticals Limited
Shameem Golam M
LandOfFree
Analogs of glycyl-prolyl-glutamate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs of glycyl-prolyl-glutamate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs of glycyl-prolyl-glutamate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671885